Brokerages Set Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Price Target at $20.20
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) has received an average recommendation of “Buy” from the six brokerages that are covering the stock, MarketBeat reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokerages […]
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) has received an average recommendation of “Buy” from the six brokerages that are covering the stock, MarketBeat reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokerages […]
